BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 8051400)

  • 1. Multiple glycosylphosphatidylinositol-anchored Ly-6 molecules and transmembrane Ly-6E mediate inhibition of IL-2 production.
    Fleming TJ; Malek TR
    J Immunol; 1994 Sep; 153(5):1955-62. PubMed ID: 8051400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of nuclear factor-kappa B and activator protein-1 activities after stimulation of T cells via glycosylphosphatidylinositol-anchored Ly-6A/E.
    Ivanov V; Fleming TJ; Malek TR
    J Immunol; 1994 Sep; 153(6):2394-406. PubMed ID: 7915738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of Ly-6A/E and T cell receptor-zeta for IL-2 production. Phosphatidylinositol-anchored Ly-6A/E antagonizes T cell receptor-mediated IL-2 production by a zeta-independent pathway.
    Codias EK; Fleming TJ; Zacharchuk CM; Ashwell JD; Malek TR
    J Immunol; 1992 Sep; 149(6):1825-52. PubMed ID: 1387661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Down-regulation of IL-2 production by activation of T cells through Ly-6A/E.
    Codias EK; Rutter JE; Fleming TJ; Malek TR
    J Immunol; 1990 Sep; 145(5):1407-14. PubMed ID: 2143518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of TCR-mediated signaling pathway by thymic shared antigen-1 (TSA-1)/stem cell antigen-2 (Sca-2).
    Saitoh S; Kosugi A; Noda S; Yamamoto N; Ogata M; Minami Y; Miyake K; Hamaoka T
    J Immunol; 1995 Dec; 155(12):5574-81. PubMed ID: 7499840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Internalization of phosphatidylinositol-anchored lymphocyte proteins. I. Documentation and potential significance for T cell stimulation.
    Bamezai A; Goldmacher V; Reiser H; Rock KL
    J Immunol; 1989 Nov; 143(10):3107-16. PubMed ID: 2572642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subsets of activated CD4 T lymphocytes refractory for secretion of IL-2 are distinguished by expression of Ly-6A/E in BALB/c mice.
    Codias EK; Malek TR
    J Immunol; 1993 Dec; 151(11):5918-29. PubMed ID: 7902374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of T lymphocytes through the Ly-6 pathway is defective in A strain mice.
    Malek TR; Shevach EM; Danis KM
    J Immunol; 1989 Jul; 143(2):439-45. PubMed ID: 2525586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The augmentation of surface Ly-6A/E molecules in activated T cells is mediated by endogenous interferon-gamma.
    Dumont FJ; Boltz RC
    J Immunol; 1987 Dec; 139(12):4088-95. PubMed ID: 3121727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cytoplasmic and the transmembrane domains are not sufficient for class I MHC signal transduction.
    Gur H; Geppert TD; Wacholtz MC; Lipsky PE
    Cell Immunol; 1999 Feb; 191(2):105-16. PubMed ID: 9973532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of T lymphocyte function by glycosylphosphatidylinositol (GPI)-anchored proteins.
    Malek TR; Fleming TJ; Codias EK
    Semin Immunol; 1994 Apr; 6(2):105-13. PubMed ID: 8054537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycosyl phosphatidylinositol membrane anchor is not required for T cell activation through CD73.
    Resta R; Hooker SW; Laurent AB; Shuck JK; Misumi Y; Ikehara Y; Koretzky GA; Thompson LF
    J Immunol; 1994 Aug; 153(3):1046-53. PubMed ID: 8027539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thy-1-negative and Ly-1-negative variants of T cells produce interleukin 2 in response to mitogens.
    Hollander N
    J Immunol; 1987 Jul; 139(2):437-42. PubMed ID: 2885371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of B lymphocyte responses to IL-4 and IFN-gamma by activation through Ly-6A/E molecules.
    Codias EK; Malek TR
    J Immunol; 1990 Mar; 144(6):2197-204. PubMed ID: 2107254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ly-6A/E induction by interleukin-6 and interleukin-9 in T cells.
    Demoulin JB; Maisin D; Renauld JC
    Eur Cytokine Netw; 1999 Mar; 10(1):49-56. PubMed ID: 10210773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deficient CD4+ T cell proliferation in the class 1 MHC-restricted 2C TCR-transgenic mouse.
    Chen FL; Kung JT
    J Immunol; 1996 Mar; 156(6):2036-44. PubMed ID: 8690890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A humanised therapeutic CD4 mAb inhibits TCR-induced IL-2, IL-4, and IL-10 secretion and expression of CD25, CD40L, and CD69.
    Woods M; Guy R; Waldmann H; Glennie M; Alexander DR
    Cell Immunol; 1998 May; 185(2):101-13. PubMed ID: 9636688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thy-1- and Ly-6-mediated lymphokine production and growth inhibition of a T cell hybridoma require co-expression of the T cell antigen receptor complex.
    Sussman JJ; Saito T; Shevach EM; Germain RN; Ashwell JD
    J Immunol; 1988 Apr; 140(8):2520-6. PubMed ID: 2895789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of an anti-Ly-6 monoclonal antibody which defines and activates cytolytic T lymphocytes.
    Havran WL; Lancki DW; Moldwin RL; Dialynas DP; Fitch FW
    J Immunol; 1988 Feb; 140(4):1034-42. PubMed ID: 3257767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclosporin A inhibits the early phase of NF-kappaB/RelA activation induced by CD28 costimulatory signaling to reduce the IL-2 expression in human peripheral T cells.
    Nishiyama S; Manabe N; Kubota Y; Ohnishi H; Kitanaka A; Tokuda M; Taminato T; Ishida T; Takahara J; Tanaka T
    Int Immunopharmacol; 2005 Apr; 5(4):699-710. PubMed ID: 15710339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.